142 results match your criteria: "Institute of Radiation Medicine (IRM)[Affiliation]"

Superior Anti-Tumor Response After Microbeam and Minibeam Radiation Therapy in a Lung Cancer Mouse Model.

Cancers (Basel)

January 2025

Department of Radiation Oncology, TUM School of Medicine and Health and Klinikum rechts der Isar, University Hospital of the Technical University of Munich, Ismaninger Straße 22, 81675 Munich, Germany.

Objectives: The present study aimed to compare the tumor growth delay between conventional radiotherapy (CRT) and the spatially fractionated modalities of microbeam radiation therapy (MRT) and minibeam radiation therapy (MBRT). In addition, we also determined the influence of beam width and the peak-to-valley dose ratio (PVDR) on tumor regrowth.

Methods: A549, a human non-small-cell lung cancer cell line, was implanted subcutaneously into the hind leg of female CD1 mice.

View Article and Find Full Text PDF
Article Synopsis
  • Proton Minibeam Radiation Therapy has been promising in enhancing treatment efficacy compared to traditional radiation, but more research into its biological mechanisms is needed.
  • A mechanical collimation setup was developed to produce 250µm minibeams with a 1000µm spacing, with optimization using Monte Carlo simulations conducted at various proton therapy sites.
  • Results showed a peak-to-valley dose ratio (PVDR) of 10 in Dresden and 14 in Seattle, with some discrepancies between dosimetry methods that can be addressed with correction factors.
View Article and Find Full Text PDF

Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma.

Nat Biomed Eng

December 2024

Translational Pancreatic Cancer Research Center, Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar, Technical University of Munich, München, Germany.

In patients with pancreatic ductal adenocarcinoma (PDAC), intratumoural and intertumoural heterogeneity increases chemoresistance and mortality rates. However, such morphological and phenotypic diversities are not typically captured by organoid models of PDAC. Here we show that branched organoids embedded in collagen gels can recapitulate the phenotypic landscape seen in murine and human PDAC, that the pronounced molecular and morphological intratumoural and intertumoural heterogeneity of organoids is governed by defined transcriptional programmes (notably, epithelial-to-mesenchymal plasticity), and that different organoid phenotypes represent distinct tumour-cell states with unique biological features in vivo.

View Article and Find Full Text PDF

Background: Post-Therapy-Pneumonitis (PTP) is a critical side effect of both, thoracic radio(chemo)therapy (R(C)T) and immune checkpoint inhibition (ICI). However, disease characteristics and patient-specific risk factors of PTP after combined R(C)T + ICI are less understood. Given that RT-triggered PTP is strongly dependent on the volume and dose of RT [1], driven by inflammatory mechanisms, we hypothesize that combination therapy of R(C)T with ICI influences the dose-volume-effect correlation for PTP.

View Article and Find Full Text PDF

Purpose: Spinal stereotactic body radiation therapy (SBRT) has become the standard of care in management of patients with limited sites of metastatic disease, radioresistant histologies, painful vertebral metastases with long life expectancy and cases of reirradiation. Our case-based guidelines aim to assist radiation oncologists in the appropriate utilization of SBRT for common, yet challenging, cases of spinal metastases.

Methods And Materials: Cases were selected to include scenarios of large volume sacral disease with nerve entrapment, medically inoperable disease abutting the thecal sac, and local failure after prior SBRT.

View Article and Find Full Text PDF

Purpose: For women with locoregionally advanced cervical cancer, the standard of care treatment is the curatively intended chemoradiation therapy (CRT). A relationship between bone marrow (BM) dose-volume histograms (DVHs) and acute hematological toxicity (HT) has been debated recently. Aim of this study was the evaluation of BM dose constraints and HT in a contemporary patient cohort.

View Article and Find Full Text PDF

CT-based radiomics for predicting breast cancer radiotherapy side effects.

Sci Rep

August 2024

Department of Radiation Oncology, Klinikum Rechts der Isar, Technische Universität München, Ismaninger Straße 22, 81675, Munich, Germany.

Article Synopsis
  • Skin inflammation and conditions like moist epitheliolysis and edema are common acute side effects of breast radiotherapy (RT).
  • The study aimed to evaluate the effectiveness of tissue-derived radiomics features compared to total breast volume (TBV) in predicting these side effects.
  • The best predictive model used a LASSO classifier based on TBV, achieving an AUROC of 0.74, similar to the AUROC of 0.75 for TBV alone, with mammary tissue showing greater predictive power than glandular tissue.
View Article and Find Full Text PDF

Incidental dose distribution to contralateral internal mammary nodes in breast cancer patients undergoing adjuvant radiotherapy.

Clin Transl Radiat Oncol

September 2024

Department of Radiation Oncology, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Article Synopsis
  • The study investigates the lymphatic drainage to contralateral internal mammary nodes (cIMN) in breast cancer patients and highlights its neglect in current adjuvant radiotherapy practices.* -
  • It analyzes the incidental radiation dose to cIMN in 120 advanced treatment plans, noting that higher doses are observed when including internal mammary node irradiation (IMNI) and during free breathing compared to deep inspiration breath hold (DIBH).* -
  • The findings indicate that cIMN receives low radiation doses in existing randomized trials and treatment methods, prompting the need for further research on the effects of targeting cIMN in high-risk breast cancer patients.*
View Article and Find Full Text PDF

Deep learning for autosegmentation for radiotherapy treatment planning: State-of-the-art and novel perspectives.

Strahlenther Onkol

August 2024

Department of Radiation Oncology, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str., 81675, Munich, Bavaria, Germany.

Article Synopsis
  • - The article discusses the increasing role of artificial intelligence (AI) in radiation oncology, specifically its application in patient care and radiotherapy planning.
  • - It reviews AI techniques for automating the segmentation of important areas like organs at risk (OARs) and tumor volumes, highlighting improved efficiency and consistency in treatment planning.
  • - Despite challenges in applying these tools clinically, the potential for personalized treatment plans and advancements in tumor detection presents a promising future for faster and more precise radiotherapy.
View Article and Find Full Text PDF
Article Synopsis
  • GBM WHO CNS Grade 4 is a tough challenge in oncology due to its aggressive nature and limitations of conventional imaging in detecting tumor recurrence.
  • A study collected blood samples from seven GBM patients at various stages to identify gene-based biomarkers for early detection of recurrence, utilizing next-generation sequencing for analysis.
  • Results showed significant variability in gene expression among patients, with a promising indication that measuring gene expressions in whole blood could be a feasible alternative to traditional methods involving exosome isolation.
View Article and Find Full Text PDF
Article Synopsis
  • Surgical resection is the primary treatment for patients with large or symptomatic brain metastases, but there's still a risk of local failure, prompting the development of a prediction tool to identify those at high risk.
  • Data from the AURORA study included 253 patients for training and 99 for external testing, utilizing radiomic features from MRI scans to enhance prediction accuracy.
  • The elastic net regression model combining radiomic and clinical features showed a significant improvement in predicting local failure, with lower risk groups experiencing only 9% failure at 24 months compared to 74% in high-risk groups, suggesting potential for improved patient follow-up and treatment.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on developing a Deep Learning-based automatic segmentation (DLBAS) algorithm to improve the process of defining volume of interest (VOI) for radiomic analyses in extremity soft tissue sarcomas, addressing issues like time consumption and variability among observers.* -
  • The DLBAS was trained on 157 patients and tested on 87, comparing its automatic segmentations to manual delineations by radiation oncologists and residents, showing promising median dice similarity coefficients that indicate high accuracy in VOI predictions.* -
  • Despite achieving high reproducibility for radiomics feature extraction, the clinical applicability of the DLBAS predictions for radiotherapy planning was found to be limited, with radiation oncologists deeming them suitable in only
View Article and Find Full Text PDF
Article Synopsis
  • Stereotactic carbon ion radiotherapy (CIRT) is a promising treatment for inoperable hepatocellular carcinoma (HCC), showing better results in sparing surrounding healthy liver tissue compared to traditional methods.
  • A study involving 20 patients revealed no severe side effects from CIRT, achieving an 80% objective response rate and a median overall survival of 30.8 months, with consistent follow-up results indicating effective disease management.
  • The findings suggest that CIRT is a safe and efficient option for HCC treatment, especially in older patients with liver cirrhosis, without significant increase in liver dysfunction post-therapy.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on improving treatment for glioblastoma, a challenging brain cancer, by validating a new computational tumor growth model for personalized therapy.
  • Researchers analyzed data from 124 TCGA patients and 397 UCSF patients to find links between clinical outcomes and factors related to tumor growth and genetics.
  • Results indicate that certain growth parameters are significantly linked to patient survival and that the model may enhance radiation treatment planning without increasing radiation exposure.
View Article and Find Full Text PDF

Dosiomics and radiomics-based prediction of pneumonitis after radiotherapy and immune checkpoint inhibition: The relevance of fractionation.

Lung Cancer

March 2024

Department of Radiation Oncology, School of Medicine and Klinikum rechts der Isar, Technical University of Munich (TUM), 81675 Munich, Germany; Institute of Radiation Medicine (IRM), Helmholtz Zentrum München (HMGU) GmbH, German Research Center for Environmental Health, 85764 Neuherberg, Germany; Partner Site Munich, German Consortium for Translational Cancer Research (DKTK), 80336 Munich, Germany.

Objectives: Post-therapy pneumonitis (PTP) is a relevant side effect of thoracic radiotherapy and immunotherapy with checkpoint inhibitors (ICI). The influence of the combination of both, including dose fractionation schemes on PTP development is still unclear. This study aims to improve the PTP risk estimation after radio(chemo)therapy (R(C)T) for lung cancer with and without ICI by investigation of the impact of dose fractionation on machine learning (ML)-based prediction.

View Article and Find Full Text PDF

For fast neutron therapy with mixed neutron and gamma radiation at the fission neutron therapy facility MEDAPP at the research reactor FRM II in Garching, no clinical dose calculation software was available in the past. Here, we present a customized solution for research purposes to overcome this lack of three-dimensional dose calculation.The applied dose calculation method is based on two sets of decomposed pencil beam kernels for neutron and gamma radiation.

View Article and Find Full Text PDF

FLASH-radiotherapy may provide significant sparing of healthy tissue through ultra-high dose rates in protons, electrons, and x-rays while maintaining the tumor control. Key factors for the FLASH effect might be oxygen depletion, the immune system, and the irradiated blood volume, but none could be fully confirmed yet. Therefore, further investigations are necessary.

View Article and Find Full Text PDF

Enhanced RBE of Particle Radiation Depends on Beam Size in the Micrometer Range.

Radiat Res

February 2024

Institute for Applied Physics and Measurement Technology, Universität der Bundeswehr München, Neubiberg, Germany.

High-linear energy transfer (LET) radiation, such as heavy ions is associated with a higher relative biological effectiveness (RBE) than low-LET radiation, such as photons. Irradiation with low- and high-LET particles differ in the interaction with the cellular matter and therefore in the spatial dose distribution. When a single high-LET particle interacts with matter, it results in doses of up to thousands of gray (Gy) locally concentrated around the ion trajectory, whereas the mean dose averaged over the target, such as a cell nucleus is only in the range of a Gy.

View Article and Find Full Text PDF

(1) Purpose: To assess the safety and effectivity of stereotactic body radiotherapy (SBRT) on spinal metastases utilizing a simultaneous integrated boost (SIB) concept in oligometastatic cancer patients. (2) Methods: 62 consecutive patients with 71 spinal metastases received SIB-SBRT between 01/2013 and 09/2022 at our institution. We retrospectively analyzed toxicity, local tumor control (LC), and progression-free (PFS) and overall survival (OS) following SIB-SBRT and assessed possible influencing factors (Kaplan-Meier estimator, log-rank test and Cox proportional-hazards model).

View Article and Find Full Text PDF

Identification of the unfolded protein response pathway as target for radiosensitization in pancreatic cancer.

Radiother Oncol

February 2024

Department of Radiation Oncology, School of Medicine, Klinikum rechts der Isar, Technical University Munich (TUM), Munich, Germany; Institute of Radiation Medicine (IRM), Department of Radiation Sciences, Helmholtz Zentrum Munich, Neuherberg, Germany; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany. Electronic address:

Background And Purpose: Due to the high intrinsic radioresistance of pancreatic ductal adenocarcinoma (PDAC), radiotherapy (RT) is only beneficial in 30% of patients. Therefore, this study aimed to identify targets to improve the efficacy of RT in PDAC.

Materials And Methods: Alamar Blue proliferation and colony formation assay (CFA) were used to determine the radioresponse of a cohort of 38 murine PDAC cell lines.

View Article and Find Full Text PDF

Multitask Learning with Convolutional Neural Networks and Vision Transformers Can Improve Outcome Prediction for Head and Neck Cancer Patients.

Cancers (Basel)

October 2023

OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, 01309 Dresden, Germany.

Neural-network-based outcome predictions may enable further treatment personalization of patients with head and neck cancer. The development of neural networks can prove challenging when a limited number of cases is available. Therefore, we investigated whether multitask learning strategies, implemented through the simultaneous optimization of two distinct outcome objectives (multi-outcome) and combined with a tumor segmentation task, can lead to improved performance of convolutional neural networks (CNNs) and vision transformers (ViTs).

View Article and Find Full Text PDF

Patients suffering from painful spinal bone metastases (PSBMs) often undergo palliative radiation therapy (RT), with an efficacy of approximately two thirds of patients. In this exploratory investigation, we assessed the effectiveness of machine learning (ML) models trained on radiomics, semantic and clinical features to estimate complete pain response. Gross tumour volumes (GTV) and clinical target volumes (CTV) of 261 PSBMs were segmented on planning computed tomography (CT) scans.

View Article and Find Full Text PDF

The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy.

Eur J Nucl Med Mol Imaging

January 2024

Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.

Article Synopsis
  • This study looked at how well salvage radiotherapy (SRT) works for men with early recurring prostate cancer after surgery, even when their scans show no signs of the disease.
  • It involved 300 patients from 11 different centers in 5 countries and checked their survival rates after SRT treatment.
  • The results showed that most patients had good outcomes, with high chances of staying cancer-free for years, especially when they had lower PSA levels before treatment.
View Article and Find Full Text PDF

Identifying core MRI sequences for reliable automatic brain metastasis segmentation.

Radiother Oncol

November 2023

Helmholtz AI, Helmholtz Zentrum Munich, Neuherberg, Germany; Department of Informatics, Technical University of Munich, Munich, Germany; TranslaTUM - Central Institute for Translational Cancer Research, Technical University of Munich, Munich, Germany; Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Background: Many automatic approaches to brain tumor segmentation employ multiple magnetic resonance imaging (MRI) sequences. The goal of this project was to compare different combinations of input sequences to determine which MRI sequences are needed for effective automated brain metastasis (BM) segmentation.

Methods: We analyzed preoperative imaging (T1-weighted sequence ± contrast-enhancement (T1/T1-CE), T2-weighted sequence (T2), and T2 fluid-attenuated inversion recovery (T2-FLAIR) sequence) from 339 patients with BMs from seven centers.

View Article and Find Full Text PDF

Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor in adults. Despite modern, multimodal therapeutic options of surgery, chemotherapy, tumor-treating fields (TTF), and radiotherapy, the 5-year survival is below 10%. In order to develop new therapies, better preclinical models are needed that mimic the complexity of a tumor.

View Article and Find Full Text PDF